News October 24, 2024 A Unique Experience! Expo Pharma Milan 2024: Innovation and Connections for Our Clients READ MORE August 22, 2024 Wexford Laboratories launches a new product, Ondansetron 4 mg/2 mL Injectable Solution, driven by high demand projections according to studies. READ MORE March 24, 2024 Dexketoprofen 50mg/2ml Injectable Solution: A New Option for Pain Relief READ MORE December 11, 2023 Wexford announces approval of In Vitro Bioequivalence READ MORE Previous 1 2 3 Next
